A lot of the recent move has been based on hype and momentum and not fundamentals. Plenty of other biotechs on the ASX having similar moves. Great opportunity for those that play the short side imo.
What goes up on momentum and hype will eventually revert back to reality. I'm betting that $1.6b valuation is unjustified and given the rate of cash burn it will
have to pass the hat around again and again and this time will not be different.
Each to their own.
MSB Trading - 2020, page-1303
-
- There are more pages in this discussion • 21,858 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |